Skip to content

Clinical trials

Observational Thromboembolism trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thromboembolism Phase: Observational Country / region: Italy Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20121
20131
20151
20161
20181
20201
20213
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abbott Medical Devices2
Boehringer Ingelheim2
Arianna Anticoagulazione Foundation1
Bayer1
Boston Scientific Corporation1
IRCCS Azienda Ospedaliero-Universitaria di Bologna1
IRCCS Policlinico S. Donato1
Johannes Gutenberg University Mainz1
University Hospital of Ferrara1
University of Campania Luigi Vanvitelli1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thromboembolism12
Atrial Fibrillation5
Stroke4
COVID-192
Myocardial Infarction2
Thrombosis2
Cardiovascular Diseases1
Colitis, Ulcerative1
Crohn Disease1
Embolism and Thrombosis1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.